BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 12, 2003
View Archived Issues
NaPro receives SBIR grant for work in Duchenne muscular dystrophy
Read More
Vion enters research and option agreement for novel anticancer compounds
Read More
Disease stabilization in phase II multiple myeloma study of Panzem
Read More
Human challenge study of FluINsure confirms efficacy of vaccine
Read More
Safety and clinical efficacy of GW-572016 in advanced breast cancer
Read More
BMS-247550 in metastatic breast cancer
Read More
Palifermin improves quality of life in cancer patients with oral mucositis
Read More
New PARP inhibitors described by KuDOS and Maybridge scientists
Read More
GSK patent covers novel p38 MAP kinase inhibitors and their use
Read More
Schering AG researchers claim new PLK inhibitors for cancer and other uses
Read More
New opioid receptors modulators prepared and tested at Janssen
Read More
Merck KGaA claims novel semicarbazide-based factor Xa and/or factor VIIa inhibitors
Read More
Series of mGluR antagonists described by Euroceltique researchers in a recent patent
Read More
SC-12267 advanced into phase I for rheumatoid arthritis
Read More
Celmed BioSciences and NIH to test Theralux for GvHD
Read More
Grant supports matriptase inhibitor development at Curacyte
Read More
New preclinical and phase I data presented for CYC-202
Read More
Genta completes NDA submission for Genasense for malignant melanoma
Read More
Continued positive interim data from phase II extension study of Alzhemed
Read More
Immediate-release indiplon shows promise for MOTN administration
Read More
Bayer acquires Fosrenol rights in Japan
Read More
Belgian phase I trial evaluates tgAAC09
Read More
TGN-255 shows desired anticoagulant pharmacodynamic properties in phase I study
Read More
ICL-670 in beta-thalassemia and associated transfusional iron overload
Read More
Safety profile of sustained-release bupropion in epilepsy patients
Read More
Clinical benefits of pregabalin in epilepsy
Read More
Antiangiogenic PKC-beta inhibitor identified at J&J
Read More
Nonhypercalcemic vitamin D3 analogue HY-11 shows promising antileukemic activity
Read More